Vesugen
Also known as: Vessel Bioregulator, Vascular Peptide
A Khavinson bioregulator peptide for vascular health and blood vessel function.
Overview
Vesugen is a synthetic tripeptide from the Khavinson bioregulator family designed to support blood vessel health. It may help maintain vascular integrity and function, particularly during aging or in cardiovascular conditions.
Mechanism of Action
Gene regulatory effects on vascular endothelium. Proposed to normalize protein synthesis in blood vessel walls. May support endothelial function and vascular repair.
Pharmacokinetics
Small peptide allows oral/sublingual administration. Tissue-specific effects on vasculature.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Vascular Support
10-20 mg
1-2x daily
10-30 days
2-3 courses per year
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Improved vascular function markers in studies
- 2Gene expression modulation in endothelial cells
- 3Part of cardiovascular bioregulator protocols
- 4Support for aging blood vessels
Side Effects & Contraindications
Reported Side Effects
- Generally well-tolerated
Contraindications
- None well-established
Safety Considerations
Generally well-tolerated. Limited Western clinical data. May complement cardiovascular care.
Storage Requirements
Store at room temperature
Scientific References
- 1